Sunday 17 November 2019 ,
Sunday 17 November 2019 ,
Latest News
  • Onion price starts falling; wholesalers receive backlash
  • PM joins Dubai air show opening ceremony
  • Holey Artisan attack case verdict Nov 27
  • No rice crisis expected like onion: Minister
  • Gas pipeline blast kills 7, injures 15 in Ctg
  • Road Transport Act takes effect: Quader
  • Not only onion’s, prices of all essentials soaring: Fakhrul
14 October, 2019 00:00 00 AM

Prescribed Zantac heartburn medicine recall in UK

BBC News Health
Prescribed Zantac heartburn medicine recall in UK

UK doctors are being told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a "precautionary measure".

It follows concern in several countries that products may contain an impurity that has been linked to cancer.

The four being recalled are Zantac 150mg/10ml Syrup, Zantac 50mg/2ml Injection, Zantac 150mg Tablets and Zantac 300mg Tablets.

But patients should keep taking their prescribed medicine, officials advise.

The Medicines and Healthcare products Regulatory Agency (MHRA) says the health risk of discontinuing the medicine is higher than the potential risk presented by the contaminant N-nitrosodimethylamine (NDMA).

Anyone who is concerned about taking their medication should speak to their doctor or pharmacist.

What is the recall about?

NDMA is classified as a probable human carcinogen (a substance that could cause cancer) on the basis of animal studies. It is present in some foods and in water supplies but is not expected to cause harm when ingested in very low levels.

The MHRA has asked manufacturers to quarantine all products which may contain the active pharmaceutical ingredient (API) that is potentially affected by this issue.

The four in the recall are made by GlaxoSmithKline (GSK).

Over-the-counter products (Zantac 75 Relief (PL 02855/0081 [GSL]) and Zantac 75 Tablets (PL 02855/0082 [P]), which people can buy in pharmacies without a prescription, are produced by a different company and are not affected by the recall.

The MHRA is investigating other ranitidine medicines which may also be affected and will provide updates soon.

Should I be concerned?

Currently, there is no evidence that medicines containing this type of impurity have caused any harm to patients, say experts.

Dr Andrew Gray, from the MHRA, said: "Whilst this action is precautionary, the MHRA takes patient safety very seriously.

"We have asked companies to quarantine batches of potentially affected medicines whilst we investigate and we will take action as necessary, including product recalls where appropriate.

"We have also requested risk assessments from the relevant companies which will include the testing of potentially affected batches."

A spokesman for GSK said the company initiated a voluntary recall of all Zantac products "as a precautionary measure" and relayed its decision to the MHRA, which issued a UK-wide drug alert recently.

He added: "GSK is continuing with investigations into the potential source of the NDMA... and have engaged with external laboratories to conduct tests on the API and finished product batches of Zantac."

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

November 14 - the World Diabetes Day is the birth day of man who discover insulin i.e. Sir Frederick G. Benting, a Canadian Orthopedic Surgeon in 1922.…
About diabetes

About diabetes

Diabetes is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it…
WHO on diabetes

WHO on diabetes

Key facts •    The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. •    The…
Why diabetes raises your risk of falling

Why diabetes raises your risk of falling

Comedians may trip and stumble for easy laughs, but there's nothing funny about falling, which is a major health risk for older adults. Having diabetes…
6 Ways to pull yourself out of diabetes burnout

6 Ways to pull yourself out of diabetes burnout

Diabetes can be a life-threatening condition if not managed properly. But what if you find yourself… feeling unmotivated? It’s not like you…
Measles makes body 'forget' how to fight infection

Measles makes body 'forget' how to fight infection

JAMES GALLAGHER    Measles has a devastating impact on the body's immune system that could make it harder to fight infections for years,…
With liver cancer deaths on the rise, these are the symptoms to look out for

With liver cancer deaths on the rise, these are the symptoms to look out for

ALEXANDRA THOMPSON Liver cancer deaths have risen by around 50% in the past decade in the UK. [Photo: Getty] Liver cancer deaths have risen by around…
Scenario of nursing in the world

Scenario of nursing in the world

Genesis of nursing is as old as humanity. The nurturing instinct, the core of nursing, started with motherhood. As a service to sick persons it flourished…
E-cigs may damage the heart, study says

E-cigs may damage the heart, study says

ELIZABETH DONOVAN Vaping devices and the chemicals they deliver—increasingly popular among teens—may damage the cardiovascular system, a study…
Weight-loss surgery: Better health, but no cost savings

Weight-loss surgery: Better health, but no cost savings

Weight-loss surgery has many benefits for obese patients, but it might not cut the cost of their overall health care, a new study finds. Called bariatric…
FDA approves Vumerity (diroximel fumarate) for Multiple Sclerosis

FDA approves Vumerity (diroximel fumarate) for Multiple Sclerosis

Biogen Inc. and Alkermes plc recently announced that the U.S. Food and Drug Administration (FDA) approved Vumerity (diroximel fumarate), a novel oral…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting